SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-03-001053
Filing Date
2003-08-05
Accepted
2003-08-05 15:06:13
Documents
7
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDING JUNE 30, 2003 a92032e10vq.htm 10-Q 154588
3 EXHIBIT 10.11 a92032exv10w11.txt EX-10.11 59958
4 EXHIBIT 10.37 a92032exv10w37.txt EX-10.37 10065
5 EXHIBIT 10.38 a92032exv10w38.txt EX-10.38 3303
6 EXHIBIT 31.1 a92032exv31w1.txt EX-31.1 4413
7 EXHIBIT 31.2 a92032exv31w2.txt EX-31.2 4400
8 EXHIBIT 32.0 a92032exv32w0.txt EX-32.0 2212
  Complete submission text file 0000936392-03-001053.txt   241174
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 03823585
SIC: 2836 Biological Products, (No Diagnostic Substances)